Weekly Intelligence · 20 articles
Vet Industry Intel: Aug 23 – Aug 29, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Acquisitions & M&A
BiomEdit Acquires Folium Science Technology and Pipeline Assets to Expand Programmable Veterinary Biologics Capabilities - PR Newswire
BiomEdit announced the acquisition of Folium Science's technology and pipeline assets to enhance its programmable veterinary biologics capabilities.
BiomEdit · Folium Science · PR Newswire
BiomEdit Acquires Folium Science Assets to Expand Veterinary Biologics Pipeline - citybiz
BiomEdit has acquired assets from Folium Science to broaden its veterinary biologics pipeline.
BiomEdit · Folium Science · citybiz
Private Equity Pet Hospital Investors Expand In Contra Costa - Patch
Private equity investors are expanding their pet hospital portfolio in Contra Costa County, California.
Private Equity Pet Hospital Investors | CA
Funding & Investment
Optiscan Imaging Raises $17.75m, Submits First FDA Dossier in FY2026 Annual Report - Kalkine
Optiscan Imaging secured $17.75 million in funding and submitted its first FDA dossier for FY2026, marking a significant milestone for the company.
Optiscan Imaging · FDA
Optiscan Imaging Secures $17.75M, Files First FDA Dossier, and Launches InSpecta™ in FY2026 Annual Report - Kalkine Media
Optiscan Imaging raised $17.75 million, filed its first FDA dossier, and announced the launch of its InSpecta™ product in FY2026.
Optiscan Imaging · FDA
Regulatory & Policy
Endovia Health Sciences, formerly Splash Beverage, Achieves - GlobeNewswire
Endovia Health Sciences, formerly Splash Beverage, has achieved regulatory approval from the FDA's Center for Veterinary Medicine.
Endovia Health Sciences · FDA
Cronus Pharma Unveils FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - Pet Age
Cronus Pharma announced that its bioequivalent Robenacoxib injection has received FDA approval for veterinary use.
Cronus Pharma · FDA
FDA approves emergency use of generic ivermectin to prevent New World screwworm in cattle - DVM360
The U.S. Food and Drug Administration approved emergency use authorization for generic ivermectin to prevent New World screwworm infestation in cattle.
FDA
Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business? - Yahoo Finance
Zoetis received emergency authorization from the FDA for its product Simparica Trio, potentially impacting its U.S. business.
Zoetis
Argent BioPharma Secures FDA-CVM INAD for CannEpil Veterinary Cancer-Pain Program - TipRanks
Argent BioPharma has obtained FDA-CVM Investigational New Animal Drug approval for its CannEpil Veterinary Cancer-Pain Program.
Argent BioPharma · FDA-CVM
FDA authorizes generic ivermectin as U.S. screwworm cases reach 47 - AGDAILY
The U.S. Food and Drug Administration authorized the use of generic ivermectin to treat screwworm infestations, following an increase to 47 reported cases.
FDA · generic ivermectin
The Bull Case For Zoetis (ZTS) Could Change Following FDA Emergency Use Authorization For Simparica Trio - simplywall.st
Zoetis received FDA emergency use authorization for its parasite control product Simparica Trio, potentially impacting its market position.
Zoetis · FDA · simplywall.st | NJ
Certain Fromm Family Foods canned dog foods are under recall as they may contain metal. Here's what to know. See link below ⬇️ 📸 U.S. Food and Drug Administration - facebook.com
The U.S. Food and Drug Administration has recalled certain canned dog foods from Fromm Family Foods due to potential metal contamination.
U.S. Food and Drug Administration · Fromm Family Foods
Argent BioPharma Secures FDA-CVM INAD File No. 14145 for CannEpil® Veterinary Programme - Kalkine
Argent BioPharma filed an INAD with the FDA for its CannEpil veterinary program, marking a regulatory step toward approval.
Argent BioPharma · FDA
Products & Technology
Cronus Pharma Launches First FDA-Approved Generic Robenacoxib Injection for Pain Control in Dogs and Cats - BioBuzz
Cronus Pharma has launched the first FDA‑approved generic version of Robenacoxib injection for pain control in dogs and cats.
Cronus Pharma · FDA · BioBuzz
Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business? - Yahoo Finance UK
Zoetis received emergency authorization from the FDA for its product Simparica Trio, a veterinary parasite control medication, potentially bolstering its U.S. business amid a slowdown.
Zoetis · FDA
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - FinancialContent
Cronus Pharma announced the launch of its first FDA‑approved bioequivalent robenacoxib injection for veterinary use.
Cronus Pharma · FDA · FinancialContent
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - August 26, 2026 - BioSpace
Cronus Pharma has announced the launch of its first FDA‑approved bioequivalent robenacoxib injection for veterinary use, marking a new product addition to the veterinary analgesic market.
Cronus Pharma · FDA · BioSpace
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - New Castle News
Cronus Pharma announced the launch of its first FDA‑approved bioequivalent robenacoxib injection for veterinary use.
Cronus Pharma · FDA · New Castle News | DE
Cronus Pharma launches first FDA-approved injection for veterinary use to control postoperative pain in dogs and cats - ROI-NJ
Cronus Pharma has launched its first FDA‑approved injection for controlling postoperative pain in dogs and cats.
Cronus Pharma · FDA | NJ
Most-mentioned this week
BiomEdit (1) · Zoetis (1) · Private Equity Pet Hospital Investors (1)